USP <800> Compliance: A Hazardous Drug Safe Handling PPE Toolkit for Infusion Nurses

0.00

Add to Wishlist
Add to Wishlist

Description

USP <800> Compliance: A Hazardous Drug Safe Handling PPE Toolkit for Infusion Nurses, Is A Well-Researched Topic, It Is To Be Used As A Guide Or Framework For Your Research.

Summary

Problem: Safety concerns have existed for more than 40 years about how hazardous drug (HD) exposure contributes to long- and short-term adverse health outcomes for healthcare workers (HCWs). Careless handling may cause toxic residues to infiltrate hospital environments and patient care areas, and can even be traced to patients’ homes. New government regulations will require healthcare organizations to minimize exposure risks to HCWs by fully implementing the U.S. Pharmacopeia (USP) Convention Chapter 800: Hazardous Drugs: Handling in Healthcare Settings (USP, 2016) on December 1, 2019. According to Polovich and Olsen (2017), “The implementation of the USP <800> Standards will represent an important step forward for nurses
and other potentially exposed HCWs” (p. 1).

Context: The proposed Doctor of Nursing Practice (DNP) project will implement an HD safehandlingN personal protective equipment (PPE) toolkit at an ambulatory cancer infusion center to improve nurses’ adherence with the USP <800> Standards and hospital policies addressing PPE use when handling, administering, and disposing of HD.
Proposed Interventions: Interventions for this project will consist of (a) an HD safe-handling PPE toolkit for infusion nurses, (b) a PPE observation tool, (c) an expert panel discussion, (d) a nurses’ skills session, (e) safe-handling adherence between observation and self-assessment survey, (f) hazardous drug administration safe handling peer-to-peer checklist, and (g) a performance dashboard to display progress.

Proposed Outcome Measures: Outcome measures include (a) 90% or higher compliance rateswith PPE use and (b) sustained adherence to USP <800> Standards and hospital policies for safeNHD handling to 100% by February 2020.

TABLE OF CONTENTS

Section I. Title and Executive Summary
Title …………………………………………………………………………………………………………… 1
Executive Summary …………………………………………………………………………………….. 4
Section II. Introduction ………………………………………………………………………………………… 5
Problem Description ……………………………………………………………………………………. 5
Available Knowledge …………………………………………………………………………………… 6
PICOT Question ………………………………………………………………………………………….. 7
Literature Review ………………………………………………………………………………………… 7
Summary of the Evidence …………………………………………………………………………….. 11
Rationale/Conceptual Framework ………………………………………………………………….. 12
Specific Aims ……………………………………………………………………………………………… 13
Section III. Methods ……………………………………………………………………………………………… 15
Context ………………………………………………………………………………………………………. 15
Proposed Intervention ………………………………………………………………………………….. 15
Proposed Budget …………………………………………………………………………………………. 23
Proposed Outcome Measures ………………………………………………………………………… 24
Proposed Analysis ……………………………………………………………………………………….. 25
Ethical Considerations …………………………………………………………………………………. 25
Section IV. Discussion …………………………………………………………………………………………… 27
Limitations …………………………………………………………………………………………………. 27
Conclusion …………………………………………………………………………………………………. 28
Section V. References ……………………………………………………………………………………………. 29

Section VI. Appendices …………………………………………………………………………………………. 34
Appendix A. Evidence Table ………………………………………………………………………… 35
Appendix B. Commission on Cancer Program Standard 4.8 ……………………………… 48
Appendix C. Basic Steps of Compliance Flow Chart ……………………………………….. 49
Appendix D. Signed Statement of Non-Research Determination ………………………. 50
Appendix E. Gap Analysis ……………………………………………………………………………. 54
Appendix F. Gantt Chart ………………………………………………………………………………. 55
Appendix G. Work Breakdown Structure ……………………………………………………….. 56
Appendix H. Work Breakdown Structure Dictionary ……………………………………….. 57
Appendix I. Work Breakdown Structure Glossary …………………………………………… 59
Appendix J. Responsibility/Communication Matrix ………………………………………… 60
Appendix K. SWOT Analysis ……………………………………………………………………….. 62
Appendix L. Proposed Budget ………………………………………………………………………. 63
Appendix M. IRB Approval …………………………………………………………………………. 64
Appendix N. Letter of Support from Organization …………………………………………… 65
Appendix O. Proposed CQI Method and Data Collection Tools ………………………… 66
Appendix P. Dummy Tables …………………………………………………………………………. 67
Appendix Q. Key Elements of the Toolkit ……………………………………………………… 71

Brand

YourPastQuestions Brand

Additional information

Author

Cynthia Huff

No of Chapters

6

No of Pages

76

Reference

YES

Format

PDF

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.